CTSA Pharmaceutical Assets Portal
The CTSA Pharmaceutical Assets Portal invites you to join in the effort to find new uses for discontinued drugs.
The ultimate goal is to leverage existing compounds to advance mechanistic understanding of human disease, resulting in novel treatments for patients. Integration of academic investigators into collaborative repositioning efforts with Pfizer would substantially increase the knowledge base and the pool of methodologies available for proof of concept studies. These matches will undoubtedly result in an increased number of approved drugs for new indications and considerable public benefit.